Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.
about
Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cellsThe effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cellsLow fasting low high-density lipoprotein and postprandial lipemiaElevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies.Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentHypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.The vascular implications of post-prandial lipoprotein metabolismPostprandial lipemia in pre- and postmenopausal womenThe ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fatAn update on accumulating exercise and postprandial lipaemia: translating theory into practiceLipoprotein metabolism in chronic renal insufficiency.Therapeutic effects of fibrates in postprandial lipemia.Are the health benefits of fish oils limited by products of oxidation?GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects.Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjectsMethods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk.Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.The repeatability of the abbreviated (4-h) Oral Fat Tolerance Test and influence of prior acute aerobic exercise.Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.High postprandial triglycerides serum levels: is obesity a good predictor?Postprandial lipid metabolism in relation to coronary heart disease.Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction.Apolipoprotein E polymorphism and the characteristics of diseased vessels in male Chinese patients with angiographic coronary artery disease: a case-case study.Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat.The atherogenic plasma remnant-like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients.Acute-on-chronic effects of fatty acids on intestinal triacylglycerol-rich lipoprotein metabolism.Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids.Study of molecular mechanism of Prostaglandin E1 in inhibiting coronary heart disease.A low-protein diet exacerbates postprandial chylomicron concentration in moderately dyslipidaemic subjects in comparison to a lean red meat protein-enriched diet.Effect of weight loss on the postprandial response to high-fat and high-carbohydrate meals in obese women.Comparison of three fatty meals in healthy normolipidaemic men: high post-prandial retinyl ester response to soybean oil.Plasma kinetics of chylomicron-like emulsion in renal transplant patients receiving cyclosporin-based immunosuppression.Elevated remnant lipoproteins may increase subclinical CVD risk in pre-pubertal children with obesity: a case-control study.Effects of 3-month Mediterranean-type diet on postprandial TAG and apolipoprotein B48 in the Medi-RIVAGE cohort.Changes in serum triglycerides and high-density lipoprotein concentration and composition after a low-fat mixed meal. Effects of gender and insulin resistance.Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients.Effect of an acute hyperinsulinaemic clamp on post-prandial lipaemia in subjects with insulin resistance.
P2860
Q24321472-3416752B-4841-4EE2-A2D5-40A793E3E53DQ24794764-13E453C4-C7F5-4D37-997F-41DAC55CCE60Q24795932-AE36481E-B87D-4520-A46E-F0C2D3B77592Q31898299-31F7A4F9-6AEC-4EE9-ADC0-7E7F2649F191Q33306319-6ECEAD3F-B131-4BDC-9DCA-5FF6A31D0D3FQ34640735-4F39BAF4-4FAB-4735-AEB1-0E070E62FC93Q34743688-4595FAAB-C0B9-47B2-83D9-E7CBEC469107Q35029623-A681369A-B001-4ACE-8092-2982320A3143Q35176441-2496CCF5-7DEF-47DF-88EC-D2BA9FD567CFQ35754371-5DCA5234-E9F9-4D99-B00F-BA4B26B18C09Q35992933-24C75215-934B-4B75-B9F3-F73B911C41AFQ36213841-392AEAF3-339B-418D-985F-7BDF8D426D26Q36595220-F2235056-A65A-4B03-860C-6FD4A6943CE4Q36772445-CA3CC1BD-066D-4FBE-81AC-997D508825D7Q37239037-67173C5E-9CF1-4A46-BB7C-AF7373DCB09DQ37350002-9F88913E-236D-437F-BEAF-0D05A5A128E3Q37396567-92DBC2F4-2A70-47B9-9481-29CD35567A5FQ37418124-69C9EAFF-9588-4AA5-8DC9-16A5B2226166Q37534889-B0F995FA-3189-414C-93F4-FC5943C720B4Q38076370-0FE077CD-488B-44C5-A66E-B761474BF951Q38811488-E0072A43-EFCF-4E6F-8356-9448D3A080A3Q38903993-7DD551BE-FF30-4CCC-B299-667B22F8952BQ41480218-32467BA2-FD5B-438C-9FB5-0F5919B2F8EEQ41571799-7B98F177-6768-421E-BDE2-751240023C60Q41906133-8717A6B8-7057-48B6-9817-2AD2A9F9F58DQ43019264-F8F43D91-73D3-46B3-A53D-91C38DFDDBBEQ43241287-FAF17F50-52AF-45A8-B4CC-5B436703A7ADQ43674509-6DEF7FE9-459A-457A-B836-DA7796A3DB84Q44256748-549AE868-AAC6-412A-A8F1-A570CBC95E53Q44700534-598AF2EF-7592-431A-9512-026DA28177DEQ45778627-7A1B0154-B053-4669-AA04-47FB2E339E93Q46598990-894831DC-DEE3-4987-B1E2-C293FB530F92Q47305386-B360F8C9-09DA-4AE6-BB5D-A96802F477C8Q47897250-BADA402C-457F-4891-9A5E-EE9CAEAB7ABDQ47959757-2C524D5C-A6FA-4127-9E0F-F36456164460Q51347645-92119DE3-0D34-4293-BE08-1101BBF75D9AQ51364053-9D26E782-8893-45BF-8EDD-60B5D308F45CQ51481174-0CF95919-A530-4B18-9360-4E6F3F39EACAQ51482875-F7C4E14F-5F6C-4899-808C-4D277DFE21E9Q51495918-718812FB-6325-4C1D-BCA6-4840479C8570
P2860
Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Clearance of chylomicron remna ...... ontrol study over three years.
@ast
Clearance of chylomicron remna ...... ontrol study over three years.
@en
type
label
Clearance of chylomicron remna ...... ontrol study over three years.
@ast
Clearance of chylomicron remna ...... ontrol study over three years.
@en
prefLabel
Clearance of chylomicron remna ...... ontrol study over three years.
@ast
Clearance of chylomicron remna ...... ontrol study over three years.
@en
P2093
P2860
P356
P1433
P1476
Clearance of chylomicron remna ...... ontrol study over three years.
@en
P2093
Grosskopf I
Rotmensch HH
Rubinstein A
Weintraub MS
P2860
P304
P356
10.1136/BMJ.312.7036.935
P407
P577
1996-04-01T00:00:00Z